Summary of study ST000288

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000230. The data can be accessed directly via it's Project DOI: 10.21228/M8XG6C This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  |  Download all metabolite data  |  Perform analysis on untargeted data  |  Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data (Contains raw data)
Study IDST000288
Study TitleMetabolomic profiling of AML Cell Lines
Study TypeIn vitro study
Study SummaryIn vitro study with AML cell lines that are treated with different concentrations of cytarabine (nucleoside analog). 8 AML cell lines were incubated for 24hr with 0uM, 1uM and 10uM ara-C. After 24hr the cells were washed and pellets were stored in -80°C for genomic and metabolomic analysis.
Institute
University of Florida
DepartmentSECIM
Last NameBhise
First NameNeha
Address-
Emailnbhise@cop.ufl.edu
Phone352-294-5745
Submit Date2015-02-15
Num Groups3
Total Subjects24
Raw Data AvailableYes
Raw Data File Type(s).raw, .mzML
Analysis Type DetailLC-MS
Release Date2016-12-22
Release Version1
Neha Bhise Neha Bhise
https://dx.doi.org/10.21228/M8XG6C
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Project:

Project ID:PR000230
Project DOI:doi: 10.21228/M8XG6C
Project Title:Identification of Factors Influencing Nucleoside Analog Sensitivity
Project Summary:The metabolomic profiles of cytogenetically different AML cell lines are associated with variability in response of these cell lines to nucleoside analogs. The treatment with nucleoside analog (cytarabine) would result in changes in the metabolomic profile of the AML cell lines.
Institute:University of Florida
Department:Pharmacotherapy and Translational Research
Last Name:Lamba
First Name:Jatinder
Address:-
Email:jlamba@cop.ufl.edu
Phone:352-273-6425
  logo